Clin2
NCT06310967Possibly a fitRecruiting

Study of IG3018 for high uric acid with or without kidney disease

HyperuricemiaHypouricemia, Renal

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests a new medicine, IG3018, to lower high uric acid levels in people with or without chronic kidney disease. It aims to find the right dose and see if it's safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have high uric acid (measured in blood, typically above a certain level).
  • Your kidney function is stable, and you either have healthy kidneys or Stage 3a-4 chronic kidney disease (not on dialysis).
  • You have not had gout flares requiring treatment in the last month.
  • You can stop other urate-lowering medicines (like allopurinol) for the study.
  • You are not pregnant or planning pregnancy, and you use effective birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06859073Recruiting· Phase 1
Safety study of NNC4004-0002 for high uric acid without symptoms

This study tests a new medicine, NNC4004-0002, for people who have high uric acid levels but no gout symptoms. The goal is to see if it is safe and how well it works in healthy adults aged 35 to 75.

Glendale, California
NCT06629376Recruiting· Phase 1
Testing a new gout drug for safety and effect on uric acid

This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.

Shanghai
NCT07323095Not yet recruiting· Phase 2
A new medicine for high uric acid in kidney disease

This trial tests a new medicine (ABP-671) to see if it can safely lower high uric acid levels in people who also have chronic kidney disease. If you join, you might get the new drug and help researchers find a better way to manage your condition.

Gosford, New South Wales
NCT07498647Not yet recruiting· Phase 2
Testing a new tablet for gout and high uric acid

This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.

NCT07842497Not yet recruiting· Phase 2
Study of IBI3011 for acute gout flare

This study tests a new medicine called IBI3011 to see if it can reduce pain and inflammation during an acute gout flare. It's for people whose current gout flare treatments haven't worked well or caused side effects.

Jing’an, Shanghai Municipality
NCT06420401Recruiting
Prebiotics for lowering high uric acid

This trial tests whether taking prebiotics (special plant fibers that feed healthy gut bacteria) can help lower high uric acid levels. If you have high uric acid but are not on medication for it, this study may offer a natural approach to manage your condition.

Guangzhou, Guangdong

Hear when a new Hyperuricemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.